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Abstract Endothelial cells (ECs) represent the major compo-
nent of the embryonic pancreatic niche and play a key role in
the differentiation of insulin-producing β cells in vivo.
However, it is unknown if ECs promote such differentiation
in vitro. We investigated whether interaction of ECs with
mouse embryoid bodies (EBs) in culture promotes differen-
tiation of pancreatic progenitors and insulin-producing cells
and the mechanisms involved. We developed a co-culture
system of mouse EBs and human microvascular ECs
(HMECs). An increase in the expression of the pancreatic
markers PDX-1, Ngn3, Nkx6.1, proinsulin, GLUT-2, and
Ptf1a was observed at the interface between EBs and ECs
(EB-EC). No expression of these markers was found at the
periphery of EBs cultured without ECs or those co-cultured
with mouse embryonic fibroblasts (MEFs). At EB-EC
interface, proinsulin and Nkx6.1 positive cells co-expressed
phospho-Smad1/5/8 (pSmad1/5/8). Therefore, EBs were
treated with HMEC conditioned media (HMEC-CM) sus-
pecting soluble factors involved in bone morphogenetic
protein (BMP) pathway activation. Upregulation of PDX-1,
Ngn3, Nkx6.1, insulin-1, insulin-2, amylin, SUR1, GKS, and
amylase as well as down-regulation of SST were detected in
treated EBs. In addition, higher expression of BMP-2/-4 and
their receptor (BMPR1A) were also found in these EBs.
Recombinant human BMP-2 (rhBMP-2) mimicked the effects
of the HMEC-CMonEBs. Noggin (NOG), a BMP antagonist,
partially inhibited these effects. These results indicate that the
differentiation of EBs to pancreatic progenitors and insulin-
producing cells can be enhanced by ECs in vitro and that
BMP pathway activation is central to this process.
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Introduction
Type 1 diabetes mellitus (T1DM) affects approximately one
million Americans and results in devastating morbidity and
accelerated mortality from neurovascular complications [1].
Transplantation of a functioning β cell mass in the form of
a vascularized whole organ allograft or isolated islets can
provide normoglycemia without the need for exogenous
insulin injections or the threat of hypoglycemia [2].
However, the whole organ transplantation approach is
limited by the risks of surgery. Islet transplantation, though
safe, often requires collection of islets from several donors
and the graft is threatened by allorejection and recurrence
of autoimmunity. Both approaches, even if uniformly
successful, would be limited by the organ donor shortage.
One promising source of islets is embryonic stem cells
(ESCs), which can be expanded and repeatedly grafted to
attain the target quantity of insulin secretion. Under the
appropriate influences, ESCs are able to differentiate into
insulin-producing cells [3–11]. In vivo and in vitro studies
have demonstrated that endothelial cells (ECs) are required
for β-cell differentiation [12]. In addition, we recently
described that quail chorioallantoic membranes (CAMs)
composed of abundant blood vessels promote the differen-
tiation of mouse embryoid bodies (EBs) to different cell
lineages [13]. ECs provide basement membrane compo-
nents such as laminins and integrins (e.g., beta-1-integrin)
that are crucial for insulin gene expression in pancreatic
progenitors and vascularization within the islets of Langer-
hans [14–17]. Because over-expression of vascular endothe-
lial growth factor-A (VEGF-A), an angiogenic factor,
improves the rate of success of islet transplants and hence
reversal of hyperglycemia, an important role of ECs in islet
cell maintenance has been suggested [18]. It is known that
ECs also elaborate and secrete factors involved in organo-
genesis such as bone morphogenetic proteins (BMPs) [19,
20]. BMP signaling controls several developmental process-
es involved in pancreatic cell proliferation and differentiation
[21, 22]. Although the participation of ECs in β-cell
differentiation and function has been well studied in vivo
[12, 14–17], the influence of these cells in the specific
differentiation of ESCs into insulin-producing β cells as well
as the factors involved have not been fully explored in vitro.
We hypothesize that the in vitro interaction between ESC-
derived EBs and ECs cells (EB-EC) may augment the
differentiation of pancreatic endocrine progenitors and
insulin-producing cells, and these effects are mediated by
endothelial-derived factors such as BMPs. Our results
indicate that ECs co-cultured with EBs promote EB cell
differentiation to pancreatic endocrine progenitors and
insulin-producing β-like cells. Furthermore, BMP pathway
activation plays an important role in the differentiation process
observed at the cell-cell interface in our co-culture system.
Materials and Methods
Cells and Reagents
Mouse ESC line R1 (from (strains 129/Sv x 129/Sv-CP) F1
3.5-day blastocyst) (Samuel Lunenfeld Research Institute,
ON, Canada) passage 20-25 were plated on mitomycin C
(Sigma, St. Louis, MO) -inactivated mouse embryonic
fibroblasts (MEFs) (ATCC, Manassas, VA). Culture medium
for maintenance of these cells in their undifferentiated state
consisted of Dulbecco Modified Eagle Medium with high
glucose (DMEM-H) (ATCC, Manassas, VA), supplemented
with 15% heat-inactivated fetal bovine serum (FBS) (Omega
Scientific Inc., Tarzana), 1 mM Sodium Pyruvate, 0.1 mM
non-essential amino-acids (NEAA), 200 μM L-glutamine
(Invitrogen, Grand Island, NY), 1000 U/mL leukemia
inhibitor factor (LIF) (Chemicon, Temecula, CA) and
100 μM β-mercaptoethanol (Sigma, St. Louis, MO). MEFs
were grown at 37oC under 10% CO2 in DMEM-H
supplemented with 15% FBS. To induce formation of EBs,
the ESCs were cultured in hanging drops after disaggregating
with accutase (Innovative Cell Technologies, San Diego, CA).
Six hundred cells were plated in each drop of 20 μL hanging
on the lid of a Petri dish for two days. The medium used was
the same as described above, but without LIF and supple-
mented with 20% heat-inactivated FBS. After two days in
hanging drops, more medium was added to EBs that grew in
suspension for three more days. The HMEC cell line was
donated by E. W. Ades and F. J. Candal from the CDC
(Atlanta, GA) and T. J. Lawley (Emory University, Atlanta,
GA). These cells retain specific markers for microvascular
endothelial cells [23, 24]. Confluent monolayers were grown
at 37oC under 5% CO2 in MCDB131 medium (Invitrogen,
Carlsbad, CA) supplemented with 200 μM L-glutamine
(Invitrogen, Carlsbad, CA), 10% FBS (Omega Scientific,
Tarzana, CA), and 100 μg/mL Endothelial Cell Growth
Supplement (ECGS) (Upstate, Temecula, CA). Cells were
used at passages 20 to 25. Primary cultures of mouse aortic
endothelial cells (mAECs) were kindly donated by Dr. M.
Arditi (Division of Pediatric Infectious Diseases and Cardiol-
ogy, Atherosclerosis Research Center, Cedars Sinai Medical
Center, Los Angeles, CA). The method used for isolation of
these cells, that express specific endothelial-cell markers, has
been previously described [25]. Confluent monolayers of
mAECs grew in identical conditions as described for
HMECs (see above). The cells were used at passages 7
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to 10. Confluent monolayer of EOMA cells (hemangioendo-
thelioma) (ATCC, Manassas, VA) grew in DMEM-H
supplemented with 10% FBS. For co-culturing experiments,
25-30 EBs were taken with a Pasteur pipette and placed into
a 12-well plate with glass coverslips pre-coated with 0.1%
gelatin type A (Sigma, St. Louis, MO). After 24 hrs, ECs
were plated at subconfluency (75X103 cells/mL) together
with growing EBs. Then, the medium was changed to
medium with knockout serum replacer (KOSR) to avoid
further differentiation induced by FBS. The co-culture
continued for 15 days. At this time, the EBs were 20 days
of age (EBd20). In other experiments, ECs were plated on
12 mm Millicell filter inserts (Millipore, Billerica, MA) with
EBs on the bottom of the wells of a 24-well plate to avoid
cell-cell contact. After 15 days in co-culture, the EBs were
analyzed. In another group of experiments, EBs were
cultured without ECs for 15 days in HMEC conditioned
medium (HMEC-CM) or recombinant human BMP2
(rhBMP-2). EBs cultured alone or co-cultured with
MEFs were used as controls. To evaluate cell viability,
ECs, EB cultured alone, EB co-cultured with ECs, and
EBs treated with HMEC-CM were disassociated after
15 days. A sample of the cell suspension was incubated
with trypan blue and the cells were counted using a dual-
chamber hemocytometer. To evaluate apoptosis, we used
anti-PARP antibody (Millipore, Billerica, MA) in all EB
groups and ECs after 15 days in culture. A mouse insulinoma
cell line beta-TC-6 (ATCC, Manassas, VA) was also used as a
control. Suitable immunodetection of islet markers was
performed in these cells (Supplementary Fig. 1). Subcon-
fluent monolayers were grown at 37oC under 5% CO2 in
DMEM-H supplemented with 10% FBS.
EBs Treated with HMEC-CM, HMEC-CM + Noggin
(NOG), or BMPs
HMECs became confluent at day 6 after plating. At this time,
the media was replaced by media supplemented with KOSR,
collected and filtered (0.22 μm) after 24 hrs to be used as
HMEC-CM. Then, it was added directly to growing EBs. The
media was replaced every two days. rhBMP-2 and rhBMP-4
were used at 100 ng/mL and 30 ng/mL respectively (R&D
Systems, Inc., Minneapolis, MN). NOG was used to antago-
nize BMP bioactivities as previously reported [26]. It was used
at 100 ng/mL (R&D Systems, Inc., Minneapolis, MN) and
added to EC-CM. EBs treatedwith HMEC-CM,HMEC-CM+
NOG, or BMP-2/-4 were analyzed after 15 days.
Immunocytochemistry
EBs plated on coverslips and co-cultured with ECs for
15 days, were fixed with paraformaldehyde 4% (Poly-
sciences, Inc., Warrington, PA) and permeabilized with
0.3% triton X-100. After rinsing with PBS, cells were
blocked with PBS/5% BSA for 1 h and exposed overnight
using antibodies to proinsulin, glucose transporter-2
(GLUT2), pancreatic and duodenal homeobox factor-1
(PDX-1), PARP (AB3565), (Millipore, Billerica, MA),
neurogenin 3 (Ngn3) (Lifespan Biosciences, Seattle, WA),
NK homeobox 6.1 (Nkx6.1) (DSHB, University of Iowa,
IA), islet-1 (Isl-1), pancreas transcription factor 1 alpha
(PTF1a) (abcam, San Francisco, CA), platelet/endothelial
cell adhesion molecule (CD31) (BD Biosciences Pharmingen,
San Diego, CA), phospho-Smad1/5/8 (pSmad1/5/8) (Cell
Signaling, Danvers, MA), mouse IgG1, rabbit IgG, and rat
IgG2a (isotype controls; Santa Cruz, Biotechnology, Inc.,
Santa Cruz, CA). The secondary antibodies used were Alexa
Fluor 555 goat anti-rabbit IgG, Alexa Fluor 555 goat anti-
mouse IgG, Alexa Fluor 488 goat anti-mouse IgG, Alexa
Fluor 594 goat anti-rat IgG, Alexa Fluor 488 goat anti-rat
IgG (Molecular Probes, Eugene, OR). Images were acquired
with a multi-purpose zoom microscope (Nikon AZ 100,
USA; http://www.nikon.com/) attached to a DS-Qi1 High-
sensitivity CCD Camera (http://www.nikon.com/) and ana-
lyzed using an imaging software NIS-Elements AR 3.10
(Nikon Instruments, Melville, N.Y.) and the image tools of
ImageJ 1.30v software (Wayne Rasband National Institutes
of Health; USA).
Quantitative Real Time RT-PCR (qRT-PCR) Analysis
Total RNA was isolated from 100 EBs growing under the
different conditions described using RNA easy mini kit
(Qiagen, Valencia, CA). After cDNA synthesis, using a
QuantiTect Reverse Transcription kit (Qiagen, Valencia,
CA), quantitative real-time RT-PCR (qRT-PCR) analysis was
performed using a SYBR Green RT-PCR kit (Qiagen,
Valencia, CA) and the LightCycler instrument (AB Applied
Biosystems, Foster City, CA; http://www3.appliedbiosystems.
com/AB_Home/index.htm). PCR cycle conditions included a
first step for initial polymerase activation for 10 min at 95°C
and 45 cycles of denaturation at 94°C for 30 s, annealing at
60°C for 20 s, and elongation at 72°C for 30 s.
The forward and reverse primers used (all sequences are 5’-
3’) for mouse genes were as follows: Amylase,
ATACTCTGCTTGGGACTTTAACGA, and CAGAAGG
CCAGTCAGACGA; Amylin, GCCACGTGTGCCACACA,
and GTTGTTGCTGGAACGAACCA; BMP-2 ,
CTGCCTGCACCCTGTTCTCT, and GTTCAAACAC
ATATCCCTGGAAAGA; BMP-4, GGTCCAGGAAG
AAGAATAA, and GGTACAACATGGAAATGG;
BMPR1A , GAAGTTGCTGTATTGCTGA, and
GTAATACAACGACGAGCC; GAPDH, ATTGAC
CACTACCTGGGCAA, and GAGATACACTTCAAC
ACTTGACCT; GCG , GCACATTCACCAGC
GACTACAG , a n d GGGAAAGGTCCCTTC
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AGCATGTCT; GKS, GAGTGCTCAGGATGTT
AAGGATCTG, and GCTTTTGAGACCCGTTT
TGTG; GLUT2, GGATAAATTCGCCTGGATGA, and
TTCCTTTGGTTTCTGGAACT; Insulin-1, AACAG
CATCTTTGTGGTCCC, and CACTTGTGGGTCCT
CCACTT; Insulin-2, GGCTCTCTACCTGGTGTGT, and
TGCAGCACTGATCTACAATG; Isl-1, CACAGCA
CCAGCATCCTCTCT, and GAGGGAGTAATGTCC
ACAGTGAAA; K i r 6 . 2 , GGACCTCCGAAAG
AGCATGA , a n d GCGCACCACCTGCATGT;
MafA, CTTCAGCAAGGAGGAGGTCATC, and
CGTAGCCGCGGTTCTTGA; NeuroD1, CGCAT
C AT GAGCGAG TCATG , a n d G ACGTGCC
TCTAATCGTGAAAGA; Ngn3 , ACAGGCCC
AAGAGCGAGTT, and TTCTTGCGCCGGCTTCT;
Nkx2.2, CAAATTTCGCTCCTTCGTTGTAA, and
ATA CAGGCCCAT C CAGAACG T ; N k x 6 . 1 ,
T C A G G T T C A A G G T C T G G T T C C A , a n d
CGGTCTCCGAGTCCTGCTT; Pax4, GCCGAGGCAC
TGGAGAAA, and CGGGCCACTGAATCTGGAT;
Pax6 , ACCTGTCTCCTCCTTCACATCAG, and
TTGGTGAGGGCGGTGTCT; PDX-1, ATGAAATCC
ACCAAAGCTC, and GATGTGTCTCTCGGTCA
AGT; SST, CGAGCCCAACCAGACAGAGA, and
CATTGCTGGGTTCGAGTTGG; SUR1, CCTCC
AGAAGGTGGTGATGAC, and TCTGCACTCAG-
GATGGTGTGTAC. The forward and reverse primers used
(all sequences are 5’-3’) for human genes were as follows:
BMP-2 , AAAGGGCATCCTCTCCACAA, and
AGGCGTTTCCGCTGTTTG; BMP-4, CCAAGC
GTAGCCCTAAGCAT, and GGCGCCGGCAGTTCTT;
GAPDH, AGCCACATCGCTCAGACACC, and GTA
CTCAGCGGCCAGCATCG. Total RNA from beta-TC-6
cells (American Type Culture Collection, Manassas,
VA), mouse pancreas (Clontech, Mountain View, CA),
MEFs, and ECs was used as positive and negative
controls respectively. Additionally, RNA not treated with
Reverse Transcriptase (No RT) was used as internal
control. All samples were run in triplicate and PCR
products were observed by gel electrophoresis on 2%
agarose ethidium bromide-stained gels. Analysis was
performed using 7300 Sequence Detection Software
(SDS) Version 1.3 (Software Core Application, AB
Applied Biosystems, Foster City, CA; http://www3.
appliedbiosystems.com/AB_Home/index.htm). Following
qRT-PCR, a dissociation curve was run to detect primer
dimmers, contaminating DNA, and PCR products from
misannealed primers. For quantification, we used a
standard curve obtained by running a glyceraldehyde 3-
phosphate dehydrogenase (GAPDH)-plasmid with a
known copy-number value based on its molecular weight.
Automatic baseline and threshold feature (Ct) of the SDS
software (auto Ct) was performed and the system
considered Ct values established in the geometric phase
of the amplification curve for each marker with minimal
standard deviation. The standard curve was then used as a
reference for extrapolating quantitative information for
mRNA targets of unknown concentrations. Then, the
number of copies of each specific marker was divided by
the number of copies of GAPDH for normalization (mouse
housekeeping gene).
Cytokine Determination
BMP-2 was measured by MicroELISA (Quantikine Immu-
noassay, R&D Systems, Minneapolis, MN) in HMEC-CM
and mAEC-CM from confluent monolayers grown in T-75
flasks. The minimum detectable dose (MDD) by this assay
ranged from 4.3–9 pg/mL (mean was 11 pg/mL).
Statistics
Data are expressed as mean ± standard error of absolute
quantification of gene expression values in relation to house-
keeping genes from three independent experiments. To find
significant differences in the tested EB groups, the values were
assessed by Student’s t-test using GraphPad Prism Software
Version 5.01 (GraphPad Software, Inc. La Jolla, CA).
Results
EB-EC Interface
Embryoid bodies developed in hanging drops for two days
and then in suspension for three more days (Fig. 1a). After
Fig. 1 Formation of EBs and a co-culture system. mESCs were
disassociated and culture in hanging drops for 2 days. After this
period, EBs grew in suspension for additional 3 days (a). At day 5,
EBs were plated on coverslips or plastic either alone (b) or in contact
with HMECs (black arrows in c). At day 15, an EB-EC interface with
close cell-cell interaction was established (black arrowheads in d). (a),
(b), (c), and (d) Bar=100 μm
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transferring, they attached to the culture dish surface and
some cells spread out at the periphery (Fig. 1b). Cells
spreading from EBs established close interactions with the
feeder layer when plated together with HMECs (black
arrows in Fig. 1c). After 15 days, a tight EB-EC interface is
formed and changes in morphology were observed in EB
peripheral cells (black arrowheads in Fig. 1d). At this time,
the percentage of viable cells was higher than 90%. In
addition, cleaved poly ADP-ribose polymerase (PARP), an
apoptosis marker, was found in the center of some EBs but
not at EB-EC interface or in EC cultures at the analyzed
time points (not shown).
Expression of Progenitor and β-Cell Markers at EB-EC
Interface
Culture of EBs for 15 days with HMECs resulted in
expression of progenitor and β-cell markers, with high levels
of PDX-1 expression in cells located at the EB-EC interface
(Fig. 2a and b). In all of the microphotographs, ECs appear
to the left and EB cells to the right in co-cultured EBs as
indicated. The yellow arrows indicate the EB-EC interface.
In addition to specificity of the ani-PDX-1 antibody, PDX-1
induction was specifically attributed to the inductive effects
of ECs, as its expression was remarkably lower in EBs
cultured without HMEC support and its distribution was
mainly in EB center (Supplementary Fig. 2c) but not at EB-
EC interface (Fig. 2c). Also, PDX-1 expression was not
observed at the EB-MEF interface (Fig. 2s). Aside from
expression of PDX-1, significant expression of other markers
related with β-cell differentiation and function such as Ngn3
(Figs. 2d and e), Nkx6.1 (Fig. 2g and h), proinsulin (Figs. 2j
and k), and GLUT2 (Fig. 2m and n) was detected at the EB-
EC interface. In contrast, no expression of Ngn3 (Fig. 2f),
Nkx6.1 (Fig. 2i), proinsulin (Fig. 2l), and GLUT-2 (Fig. 2o)
was found at the periphery of EBs cultured without
HMECs. In addition, more expression of the exocrine
progenitor marker Ptf1a was observed at EB-EC interface
(Figs. 2p and q) compared to EBs cultured alone (Fig. 2r).
Proinsulin was selected to avoid possible uptake of insulin
from the medium and/or feeder cells. Non-selective
staining for these markers was observed at the EB-EC
interface staining with isotype control antibodies (Figs. 2t
and u). These data demonstrate superior expression of
proinsulin and GLUT2, abundant in mouse β cells, as well
as higher expression of characteristic transcription factors,
found in pancreatic endocrine and exocrine progenitors, at
the EB-EC interface.
BMP Pathway Activation at the EB-EC Interface
More complex vascular networks were found in the center
of EBs co-cultured with HMECs (Supplementary Fig. 2g)
in comparison to EBs cultured alone (Supplementary Fig. 2i),
with mAECs or EOMA cells (not shown). Considering prior
reports on the effects of BMP-2/-4 in organogenesis and
blood vessel maturation [27, 28], we suspected that these
cytokines were involved in the promotion of progenitor and
insulin-producing cell differentiation in co-cultured EBs.
Since rhBMP-2 mimicked the effects on vascular networks
induced by HMEC-CM (Supplementary Fig. 2k) and less
robust vasculature was observed on EBs treated with
rhBMP-4 (not shown), we focus our analysis in BMP-2
effects. In addition, previous studies have pointed out the
role of BMP-2 in exendin-4-induced insulin-producing cell
differentiation of AR42J cells [28]. For a functional
involvement of the BMP receptor (BMPR1A), we assessed
Smad1/5/8 phosphorylation and nuclear translocation [29].
EB cells at the EB-EC interface were found to co-express
nuclear pSmad1/5/8 and cytoplasmic proinsulin (Figs. 3a, b
and c). Higher-magnification images of these cells are shown
in the insets of Fig. 3a, b, and c. The yellow arrows indicate
the EB-EC interface. Co-expression of pSmad1/5/8 and
Nkx6.1 was also found exclusively at the EB-EC interface
(Figs. 3d, e and f). However, no co-expression was observed
in Ptf1a positive clusters close to the EB-EC limit (Figs. 3g, h,
and i). No staining was detected in those EB treated with
isotype control antibodies at the EB-EC interface (Figs. 3j, k,
and l). No proinsulin+/pSmad1/5/8+ cells were found in
either EBs cultured without ECs or at the EB-MEF interface
(not shown). These data point to specific activation of the
BMP signaling pathway by HMEC interaction as an
inductive factor in differentiation of EBs towards endocrine
progenitor cells and insulin-producing cells.
HMEC-CM Promotes EB Cell Expression of Pancreatic
Progenitor and β-Cell Markers
The inductive effects of human ECs over murine EBs and
the BMP pathway activation led to the assumption of
involvement of soluble factors. Therefore, HMEC-CM was
applied to EBs to induce expression of pancreatic progen-
itor, β-cell, islet, and exocrine markers at 15-day intervals,
considering that the most significant effects of HMECs on
EBs in co-culture were observed at this time. Expression of
PDX-1, Ngn3, and Nkx6.1 in EBs were markedly elevated
by incubation with HMEC-CM (Fig. 4a). No significant
increase was detected for neurogenic differentiation 1
(NeuroD1), paired box gene 4 (Pax4), paired box gene 6
(Pax6) and mammalian homologue of avian musculoapo-
neurotic fibrosarcoma oncogene A (MafA) (Fig. 4a).
Upregulation of PDX-1 was accompanied by increase in
mRNA encoding insulin-1, insulin-2, and amylin, (Fig. 4b)
as well as downregulation of somatostatin (SST) (Fig. 4c).
The glucose sensing and insulin secretion mechanisms are
of outmost importance towards a possible physiological
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Fig. 2 Progenitor and β-cell
marker expression at the inter-
face EB-EC. The EB cells
located in the vicinity of
HMECs (yellow arrows)
expressed PDX-1 (red) (a and
b), Ngn3 (red) (d and e),
Nkx6.1 (red) (g and h),
proinsulin (green) (j and k),
GLUT2 (red) (m and n), and
Ptf1a (green) (p and q). EBs
cultured alone were also stained
to PDX-1 (c), Ngn3 (f), Nkx6.1
(i), proinsulin (l), GLUT-2 (o),
and Ptf1a (r). To demonstrate
specificity of the inductive
effects of ECs, the co-culture
between EBs and MEFs was
also stained with specific
antibodies to these markers.
Staining with anti-PDX-1
antibody is shown as example
(s). Staining using isotype con-
trol antibodies are also shown
(t and u). (a), (j), and (r)
Bar=250 μm. (b), (c), (f), (i),
(l), (m), (o), (p), (s), (t), and (u)
Bar=100 μm. (d), and (g)
Bar=150 μm. (e), (h), (k),
and (n) Bar=50 μm. (q)
Bar=25 μm
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function of the differentiated ESCs, in addition to hormone
production [30]. Glucose sensing mechanisms were
assessed by expression of GLUT2, glucokinase (GKS),
the inward-rectifier potassium ion channel 6.2 (Kir6.2), and
sulfonylurea receptor (SUR1). Significant upregulation of
mRNA encoding SUR1 and GKS was mediated by HMEC-
CM (Fig. 4b). However, the media failed to promote
upregulation of GLUT2 and Kir6.2 as no significant
increase was found (Fig.4b). As expected, with evident
increase in expression of exocrine progenitor markers (see
Fig. 2k and l), amylase was also upregulated after treatment
of EBs with HMEC-CM (Fig. 4c). No upregulation was
observed for glucagon (GCG) (Fig. 4c). These data indicate
that endothelial-derived soluble factors are involved in
upregulation of some of the pancreatic endocrine and
exocrine markers since no cell-cell contact was necessary
to induce such effects.
HMEC-CM Effects Mimicked by BMP-2 and Inhibited
by NOG
A concentration of 210±0.035 pg/ml BMP-2 was detected
in HMEC-CM of a confluent monolayer using an ELISA
kit (see methods). To corroborate the transcriptional level of
this peptide, PCR products were analyzed after performing
qRT-PCR in these cells. Evident expression of BMP-2 and
BMP-4 was observed in HMECs (Fig. 4d). In addition,
analysis of BMP-2, BMP-4 and BMP receptor 1A
(BMPR1A) expression was carried out in mouse EB
cultured alone and co-cultured with either HMECs or
mAECs with or without contact (with ECs plated on filter
inserts). mAECs were tested because they exerted about
50% of the effects of HMEC in the promotion of insulin-1
expression evaluated by qRT-PCR (not shown). Interest-
ingly, mAECs exhibited high level expression of BMP-4
and BMPR1A but no expression of BMP-2 (Fig. 4e; lane
1). EBs cultured without HMECs expressed low levels of
BMP-2, BMP-4 and BMPR1A (Fig. 4e; lane 2). However,
upregulation of BMP-2 is observed when EBs were in
contact with either mAECs or HMECs (Fig.4e; lane 3 and
4). Notably, higher expression of BMP-2, BMP-4, and
BMPR1A was observed in those EBs in contact with
HMECs (Fig. 4e; lane 4). mAECs co-cultured with EBs
without cell-cell contact had no effects on BMP-2 and
BMP-4 expression. Surprisingly, mAEC-CM inhibited the
expression of BMPR1A (Fig. 4e; lane 5). In contrast,
Fig. 3 pSmad1/5/8 and proin-
sulin or Nkx6.1 co-expression at
the EB-EC interface. At EB-EC
interface (yellow arrows), pro-
insulin positive cells (green) (a)
co-expressed pSmad1/5/8 (red)
(b). The insets show these cells
at higher magnification. In these
images, proinsulin is localized
in the cytoplasm whereas
pSmad1/5/8 is distributed in the
nucleus. Nkx6.1 (green) (d) is
also co-expressed with pSmad1/
5/8 (e). No co-expression was
found in Ptf1a positive cells
(green) (g) staining to pSmad1/
5/8 (h). No staining was ob-
served using isotype control
antibodies to proinsulin (j) and
pSmad1/5/8 (k). Merged images
(c, f, i, l). (a), (b), (c), (g), (h),
and (i) Bar=50 μm. (a), (b), and
(c) Insets bar=10 μm. (d), (e),
(f), (j), (k), and (l) Bar=100 μm
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HMECs exerted upregulation of BMP-2, BMP-4, and
BMPR1A without cell-cell contact (Fig. 4e; lane 6). These
data suggest that mAECs (macrovascular endothelial cells)
require contact for some inductive effects whereas HMECs
(microvascular endothelial cells) exert most of their
inductive effects by releasing soluble factors that may act
in a paracrine fashion on EB cells in our co-culture system.
To confirm if the effects of HMEC-CM were exerted
mainly by BMP-2, we tested its effects with or without
NOG as well as the direct effects of rhBMP-2 on EBs.
NOG is a peptide that antagonizes BMP bioactivity by
blocking BMP epitopes involved in binding both type I and
type II receptors [26, 31]. The pattern of marker expression
(PCR products in agarose gel) from one experiment is
shown as an example in Fig. 4f. Quantification of these
expression from three independent experiments is summa-
rized in Table 1. Parallel effects of HMEC conditioned
medium and rhBMP-2 on transcriptional expression of
PDX-1, Nkx6.1, insulin-1, insulin-2, amylin, and SST were
observed (Fig. 4f, lanes 2 and 4) (Table 1). However, no
similar effects were found for Ngn3. NOG was able to
inhibit culture medium effects in the expression of PDX-1,
Ngn3, insulin-1, amylin and SST (Fig. 4f, lane 3) but not in
expression of Nkx6.1 and insulin-2 (Fig. 4f, lane 3)
(Table 1). These data suggest the involvement of regulatory
endothelial-derived factors such as BMP-2 in the transcrip-
Fig. 4 Expression of progeni-
tor, β and islet cell markers as
well as BMPs in ECs and EBs
treated with HMEC-CM. Pro-
genitor markers (a), β cell
markers (b), and islet markers
(c) as well as amylase (exocrine
marker) were analyzed by qRT-
PCR in EBs after 15-day treat-
ment with HMEC-CM. * P<
0.05. **P<0.001. Expression of
BMPs in HMECs (d), mAECs
(lane 1 in panel e), EBs cultured
alone (lane 2 in panel e), EBs
co-cultured in contact with
mAECs (lane 3 in panel e), EBs
co-cultured in contact with
HMECs (lane 4 in panel e), EBs
co-cultured without cell-to-cell
contact with mAECs (plated on
cell inserts) (lane 5 in panel e),
and EBs co-cultured without
cell-to-cell contact with HMECs
(lane 6 in panel e). Expression
of some progenitor, β- and islet-
cell markers observed in EBs
cultured alone not treated with
HMEC-CM (lane 1 in panel f),
treated with HMEC-CM (lane 2
in panel f), treated with HMEC-
CM+NOG (lane 3 in panel f),
and treated with rhBMP-2 (lane
4 in panel f)
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tion of some genes that are important for β-cell function
and development. It also suggests the possibility of
alternate BMP-independent ways for activation of those
genes not affected by the inhibitory effects of NOG.
Discussion
Although diabetes mellitus dates back to antiquity, there is
still no cure for this disease. The use of exogenous insulin
replaces the function of absent islets in type 1 diabetes
mellitus but does not provide the physiological blood
glucose control necessary to stave off the neurovascular
complications due to hyperglycemia [32]. The emerging
and attractive approach of islet transplantation has been
shown be safe with resulting normoglycemia in forty-four
percent of recipients at one year after transplantation but
multiple doses of islets are often required [33]. Insulin-
producing β-like cells can be obtained from embryonic
stem cells after treatment with growth factors [4–11]. The
crucial influence of ECs in β cell differentiation has been
proven in vivo [12]. However, the inductive effects of ECs
have not been fully explored using in vitro models. Such
effects can be now studied in culture with the emergence of
ESC that form EBs when cultured in suspension. The EBs
are structures composed of cells derived from the three
germ layers (endoderm, ectoderm, and mesoderm) [34].
Section and histological analysis of EBs reveal an external
cell layer that posses numerous microvilli characteristic of
endodermal cells and express endoderm markers such as
AFP and HNF-3 β [34]. We hypothesized that ECs may
exert inductive signals to the EB-endodermal layer in vitro
to generate pancreatic cells through endothelial-inductive
factors since in vivo pre-patterned endoderm differentiation
to form islet cells is regulated by ECs [12]. It is known that
foregut epithelial cells in vivo must be surrounded by
endothelial and mesenchymal cells to undergo differentia-
tion toward endocrine pancreatic cells [12, 35]. ECs in this
pancreatic niche are essential for the differentiation of
endodermal cells but the endothelial-derived soluble factors
involved are still under investigation [36]. Precise knowl-
edge of this complex microenvironment will provide
suitable strategies to obtain well-differentiated β cells in
vitro for potential therapeutic uses. As one approach, we
optimized the conditions for co-culture of EBs and ECs and
studied cell-cell interactions at the EB-EC interface and the
mechanisms involved. We found that the differentiation of
mouse EBs into pancreatic endocrine progenitors and
insulin-producing β-like cells was enhanced in this in vitro
system and that BMP pathway activation is involved in the
process. In support of the data presented herein, previous
investigations have demonstrated that ECs promote insulin
gene expression in vivo and in vitro [12, 14, 15]. In
addition, we recently described enhancement in EB
differentiation after implantation of these cellular aggre-
gates onto quail CAMs as a surrogated vascular network
where ECs may play a crucial role for EB differentiation
[13]. In our co-culture system, expression of pancreatic
progenitor and endocrine markers was observed mainly in
the precise region where EBs and ECs cells established a
close cell-cell interaction. Specificity of these effects is
reinforced by the fact that no expression was found at the
EB-MEF interface. Paracrine signaling of the surrounding
endothelium is possible since PDX-1, Ngn3, Nkx6.1,
proinsulin, GLUT2, and Ptf1a expression was mainly seen
at the EB-EC interface and, furthermore, some of these
cells co-expressed pSmad1/5/8. It is known that the
activated BMP type I receptor phosphorylates Smad1/5/
8 inducing their translocation to the nucleus where the
transcription of target genes is activated [37]. Activation of
Table 1 Expression of mouse pancreatic markers in EBs cultured alone or treated with endothelial cell conditioned medium (EC-CM),
endothelial cell conditioned medium plus noggin (EC-CM + NOG), and bone morphogenetic protein-2 (BMP-2).
Pancreatic Marker EBs
Control +EC-CM +EC-CM+NOG +BMP-2
mSST 2.960±0.860 1.015±0.135* 3.865±1.365** 1.045±0.155◊
mAmylin 6×10-4±0.128 0.494±0.147* 2×10-4±8×10-5‡ 0.375±0.023◊◊
mInsulin-1 0.034±0.127 1.152±0.701† 3×10-4±1.7×10-5** 0.961±0.183◊◊
mInsulin-2 0.032±0.154 1.061±0.621* 0.819±0.123 0.366±0.292
mNgn3 0.010±0.006 0.049±0.017* 4×10-4±5×10-5‡ 6×10-4±4×10-4◊
mNkx6.1 4.240±1.260 11.644±1.856† 9.500±3.0 10.770±1.230◊◊
mPDX-1 0.009±0.008 0.054±0.019* 0.010±0.011** 0.088±0.015◊◊
EBs Control vs. EBs + EC-CM, * P<0.05, † P<0.01
EBs + EC-CM vs. EBs + EC-CM+NOG, ** P<0.05, ‡ P<0.01
EBs Control vs. EBs + BMP-2, ◊ P<0.05, ◊◊P<0.01
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this pathway in our experimental system was evidenced by
Smad1/5/8 phosphorylation and pSmad1/5/8 nuclear trans-
location, supporting a major role for BMPs in the
differentiation process. In addition, we detected BMP-2 in
HMEC culture medium, BMP-2/-4 in HMECs using real
time qRT-PCR, and upregulation of BMPs in those EBs
treated with HMEC-CM. BMPs are members of the TGF-β
superfamily that share significant amino acid sequence
homology [38]. Some investigations have demonstrated
that vascular endothelium is an important source of BMPs
which can regulate vasculogenesis during embryonic
development and promote organogenesis [20, 36, 39–42].
Additionally, some studies indicated that BMP receptor
signaling in β cells is required for glucose-stimulated
insulin secretion [43]. We demonstrated that no cell-cell
contact is necessary for HMECs to exert inductive effects in
EBs suggesting the role of secreted BMPs in the enhance-
ment of pancreatic marker expression. Previous studies
have also reported up-regulation of insulin gene in a rat
insulinoma cell line treated with TGF-β [44]. These studies
are compatible with the results described herein, in which
BMP-2, a member of TGF-β superfamily, up-regulates
insulin gene expression in EB cells. These facts combined
with the known potent angiogenic properties of BMP-2
previously described, suggest a role for these growth factor
in our experimental model since we found pancreatic
marker expression and stimulation of angiogenesis in
mouse EBs co-cultured with HMECs [27]. Furthermore,
most of these effects were mimicked by rhBMP-2. We
suspected that BMP-2 was one of the endothelial-derived
factors involved in the differentiation process observed in
our system for two reasons. First, rhBMP-4 had minor
effects on angiogenesis and in pancreatic marker expression
in our system (not shown). And, second, mAECs and
EOMA cells, which produced higher levels of BMP-4, had
diminished effects on insulin-1 expression compared to
HMECs (not shown). In addition, previous studies have
demonstrated that BMP-2 plays a key role in mediating
insulin gene expression in AR42J cells [28]. However, it
has been reported that BMP-2 and BMP-4 may play
synergistic roles for proper organogenesis and embryo
development [45]. It has been reported that NOG play a
role in the induction of the nervous system by antagonizing
BMPs [46]. In addition, NOG has more specific and
stronger inhibitory effects on BMPs in comparison to other
antagonists [26]. Some of our results indicated that the
effects of the HMEC-CM in the expression of some
pancreatic markers (e.g. Nkx6.1 and insulin-2) were not
inhibited by NOG. Therefore, it is likely that other EC-
derived factors could be involved in the differentiation
process observed in the present work [36]. Additionally,
markers such as Nkx6.1, also involved in neuron differen-
tiation, and insulin-2 are more broadly expressed and not
restricted to β cells [47, 48]. Our in vitro studies have
determined that ECs have a potent influence on organo-
genesis in general since we observed expression of other
specific tissue markers (not shown). Therefore, the
endothelial-derived BMPs could trigger the expression of
more BMPs from EBs with resulting enhanced differenti-
ation of various cell-lineages as we demonstrated increase
of BMPs in EBs treated with HMEC-CM. This BMP
expression promoted by BMPs has been previously
described [26, 29]. The identification and investigation of
other endothelial-derived factors involved in such differen-
tiation might be relevant to the development of pancreatic
and other tissues in vitro. In our system, we found that
upregulation of Ptf1a at EB-EC interface was not dependent
of BMPs since no pSmad1/5/8 was detected in Ptf1a-
positive cells. Ptf1a was originally discovered by its
function in the exocrine pancreas [49]. Expression of this
factor promoted by ECs has been previously described [50].
In addition, some cells were Ptf1a+/pSmad- in comparison
with proinsulin+/pSmad+ or Nkx6.1+/pSmad+ double-
positive cells in our system. These findings suggested that
BMPs could have a more important role in the differenti-
ation of endocrine cells and that other unknown EC-derived
factors may participate in exocrine differentiation indepen-
dent of the BMP pathway. Other hormones such as SST
were down regulated in our system. It has been reported
that BMPs significantly reduces the expression of SST+
interneuron precursors that may differentiate to other cell
subpopulations [51]. These observations are consistent with
our results herein in which reduction in SST expression was
found using HMEC-CM with parallel effects exerted by
rhBMP-2. In addition to hormone production, the differen-
tiated cells expressed components of the glucose sensory
apparatus and insulin secretory machinery, which would be
absolutely necessary to achieve the glucose regulatory
function in these cells. However, important genes for β
cell function such as GLUT2 and Kir6.2 that were not up-
regulated, may require other factors derived from endothe-
lium or from other cells for their expression. In the case of
GLUT2, higher expression was clearly observed by ICC
but not by qRT-PCR in our system. It is possible that the
absolute increase in expression of this molecule at the EB-
EC interface was not detected since total GLUT2 was
quantified by qRT-PCR including those glucose trans-
porter molecules expressed in other tissues [52]. Regard-
ing Kir6.2, it has been described that IEC-Pd cells
(immature rat enterocytes that express PDX-1) were able
to release insulin into the culture medium only after
transfection of islet-1 (Isl-1), a transcription factor that
facilitates the generation of endocrine islet cells and brain
cells during embryogenesis, and that these cells showed de
novo expression of Kir6.2 [53]. Apparently, expression of
PDX-1 alone is not sufficient to promote expression of
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Kir6.2. No significant increase of Kir6.2 was found in our
system after EB treatment with HMEC-CM (see Fig. 4b)
along with very low expression of Isl-1 and NK homeobox
2 (Nkx2.2) at the EB-EC interface (not shown). These
facts suggested that Isl-1 expression can be a crucial factor
to promote subsequent Kir6.2 regulation and maturation of
β cells and that other non-endothelial signals (e.g.
mesenchymal) may be involved in Isl-1 expression as
previously described [35].
In this work we investigated whether ECs enhanced the
differentiation of mouse EB cells toward pancreatic cells in
vitro. Although cell-to-cell interaction was apparent in
culture, the inductive signals involved soluble factors, most
prominently BMP-2. We described that HMEC-CM pro-
motes the expression of markers characteristic of pancreas
progenitors and insulin-producing cells. In support of
BMPs involvement, these effects were similar to those
exerted by rhBMP-2 and inhibited by NOG. Further studies
addressing other molecular and physiological properties of
this EB-EC interaction will be necessary to understand the
complete role of endothelial cells in β-cell development
and maturation.
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